You are here

  • Home
  • Archive
  • Volume 2, Issue 4
  • Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial

Citation Tools

Article menu

Download PDFPDF

Original article
Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Wangqin R, Wang X, Wang Y CHANCE investigators, et al
Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial
Stroke and Vascular Neurology 2017;2:doi: 10.1136/svn-2017-000088